-
Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches
17 Apr 2025 14:33 GMT
… and nonparametric methods in population pharmacokinetics: experts’ discussion on use … Effect of polymorphisms on the pharmacokinetics, pharmacodynamics and safety of … clearance approaches to define drug pharmacokinetics: theoretical and clinical considerations …
-
AstraZeneca, Daiichi Sankyo announce Enhertu plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in PFS vs. THP to treat HER2─positive metastatic breast cancer
22 Apr 2025 05:11 GMT
… or death, patient-reported tolerability, pharmacokinetics and safety.
DESTINY-Breast09 enrolled …
-
Major breakthrough could turn IV drugs into oral treatments for brain cancer and Alzheimer's
22 Apr 2025 02:20 GMT
… how we approach efficacy and pharmacokinetics and toxicity," Li said …
-
Race Oncology activates second site for solid tumour clinical trial
22 Apr 2025 04:19 GMT
… of critical safety, tolerability and pharmacokinetics data,” Tillett said.
The study …
-
Race Oncology Phase 1 solid tumour clinical trial for RC220 opens...
22 Apr 2025 00:02 GMT
… of critical safety, tolerability and pharmacokinetics data.
“We’re grateful for … the asset’s safety, tolerability, pharmacokinetics, maximum tolerated dose in combination …
-
Cema-Cel Data Highlight Potential in Allogeneic CAR T: Fred Locke, MD
21 Apr 2025 23:47 GMT
… the safety and efficacy and pharmacokinetics/pharmacodynamics of cema-cel …
-
Utilizing Physiologically Based Pharmacokinetic Models to Support Rational Medication in Chinese Elderly Population
21 Apr 2025 19:24 GMT
… reliable predictive capabilities.
Comparing Pharmacokinetics Between Elderly and Young … 7b01108
12. Yan H. Pharmacokinetics/Pharmacokinetics of 2.5mg… pharmacokinetic model for predicting diazepam pharmacokinetics after intravenous, oral, intranasal, …
-
3 Things You Should Know About Unresectable NSCLC
21 Apr 2025 18:13 GMT
… PFS, duration of response, OS, pharmacokinetics, and safety. Numerous other clinical …
-
Trastuzumab Deruxtecan Plus Pertuzumab Improves Progression-Free Survival in Patients With HER2+ Metastatic Breast Cancer
21 Apr 2025 18:11 GMT
… or death, patient-reported tolerability, pharmacokinetics, and safety.4
All patient …
-
T-DXd/Pertuzumab Yields PFS Benefit vs THP in HER2+ Metastatic Breast Cancer
21 Apr 2025 16:07 GMT
… or death, patient-reported tolerability, pharmacokinetics, and safety.
References
Enhertu plus …